Testing effectiveness (Phase 2)Active Not RecruitingNCT05078866
What this trial is testing
Cancer Preventive Vaccine Nous-209 for Lynch Syndrome Patients
Who this might be right for
Colorectal CarcinomaLynch Syndrome
National Cancer Institute (NCI) 45